Related by context. All words. (Click for frequent words.) 62 human hepatocytes 60 phage display technology 60 monoclonal antibody mAb 59 mesenchymal cell 59 ddRNAi 59 TLR9 agonists 59 Multi Lineage Progenitor 59 vaccine GRNVAC1 59 ACTCellerate 58 accumulate preferentially 58 Hepatocytes 58 humanized antibodies 58 Cabilly patent 58 ACTCellerate ™ 57 tumorigenic 57 embryonic progenitor 57 targeted antifolate 57 targets Galectin receptors 57 GRNOPC1 contains 57 antisense inhibitors 57 RenaZorb TM 57 small molecule agonists 56 adult mesenchymal stem 56 induced pluripotent stem cell 56 novel peptide 56 Maxy G# 56 tubulin binding 56 hepatocyte 56 HTS assay 56 ribonuclease 56 ACTCellerate TM 56 Potelligent Technology 56 Vaccinex 56 monoclonal 56 Panzem 56 Onconase 56 hESC derived 56 anti CD3 56 penetrating peptides 56 cells hESC 56 JAK3 56 effector function 55 targeting CD# 55 microvascular endothelial cells 55 proprietary phage display 55 HuCAL GOLD R 55 neural progenitor cells 55 tumorigenicity 55 CHO cell 55 TRAIL receptors 55 Systemic Delivery 55 oligodendrocyte progenitor cells 55 TRAIL receptor antibodies 55 ERK1 2 55 Euroscreen 55 Crucell PER.C6 ® 55 androgen receptor AR 55 Aviptadil 55 cytotoxicity assays 55 cyclin dependent kinase CDK 55 HepDirect 55 kidney urologic 55 histone deacetylase HDAC 55 bispecific antibody 55 neurite outgrowth 55 potent cytotoxic 55 Squalamine 54 telomerase therapeutic 54 biologic therapeutics 54 selective immunoproteasome inhibitor 54 rxRNA 54 chemokine receptors 54 anti CD3 monoclonal 54 hTERT 54 humanized monoclonal 54 immunoregulation 54 iPSC technology 54 human pluripotent stem 54 potently inhibit 54 anti CD# antibodies 54 TLR9 agonist 54 mertansine 54 MorphoSys proprietary 54 Reports Preclinical Data 54 sphingolipid 54 Cellastim 54 Potelligent 54 poly ADP ribose polymerase 54 Cytotoxic T 54 deCODE chemistry 54 cisplatin resistant 54 molecular biomarkers 54 miRNA therapeutics 54 apoptotic pathway 54 toxic misfolded proteins 54 cytolytic activity 54 cells hESCs 54 TÎ ² 4 54 deacetylase inhibitors 53 BioSante 2A/Furin technology 53 thymidylate synthase TS 53 OMP #M# 53 epothilones 53 cell hESC 53 Introgen ADVEXIN 53 TIMERx 53 siRNA therapeutics 53 Guanilib 53 polypeptides 53 immunomodulatory properties 53 chimeric antibody 53 MEK inhibitor 53 microRNA #a 53 therapeutic monoclonal antibody 53 miR #a [002] 53 histone deacetylase inhibitor 53 tolerogenic 53 A3 adenosine receptor 53 histone deacetylase HDAC inhibitors 53 novel therapeutic antibodies 53 UltiMAb 53 kallikrein 53 BXT # 53 humanized anti 53 targeting PCSK9 53 5 FU cytotoxic 53 FGFR3 53 Nanobody R 53 vascular disrupting agents 53 thalidomide Thalomid 53 lung fibroblasts 53 LNP formulations 53 HuMax TAC 53 membrane receptors 53 adipose derived regenerative 53 Nucleic acids 53 lentiviral vector 53 Locked Nucleic Acid 53 immuno modulatory 53 immunotoxins 53 polysaccharide polymer 53 Axiogenesis 53 acadesine 53 vivo fluorescence imaging 53 GVAX ® 53 mesenchymal stem cell 53 mediated autoimmune diseases 53 Captisol ® 53 PER.C6 r 53 novel anti infective 53 antiproliferative effects 53 adipogenic 53 NEUGENE R 53 lentiviral vectors 53 CD4 receptor 53 ReCyte 53 mononuclear cells 52 Nanobodies 52 neural stem cell 52 Wnt signaling pathway 52 RECALL VAX TM 52 ANTISENILIN ® 52 focal adhesion kinase FAK 52 AEG# 52 CHO cells 52 induces apoptosis 52 dasatinib Sprycel 52 Novosom 52 microRNA sequences 52 synthetic siRNAs 52 clinically validated targets 52 pan HDAC inhibitor 52 antisense drugs 52 DAS# Fludase ® 52 mimetic compounds 52 telomerase activation 52 Immunotherapeutic 52 hematopoetic 52 depsipeptide 52 antisense inhibitor 52 Initiates Clinical Trial 52 cytotoxins 52 IAP inhibitors 52 triterpenoids 52 fluorescent staining 52 tyrosine kinase receptor 52 alpha#beta# integrin 52 selective inhibition 52 stromal vascular fraction 52 RNAi gene silencing 52 Chemokine Therapeutics 52 Chinese hamster ovary 52 keratinocyte 52 PDE# inhibitors 52 RECOTHROM R 52 ProteinChip 52 prostate epithelial cells 52 ADP receptor antagonist 52 mda 7 52 Clusterin 52 adenosine A2A 52 #T# L1 52 drug GAP #B# 52 Lenocta 52 PI3K/Akt pathway inhibitor 52 drug conjugate 52 Intravenous Human 52 M2 subunit 52 compound CTCE 52 lung carcinomas 52 BioSilicon TM 52 PDL antibody humanization 52 novel peptides 52 Quark Biotech 52 kinase PI3K 52 Ovonic fuel 52 MDSCs 52 humoral responses 52 CEQ# 52 retinoic acid receptor 52 inhibit KSP 52 Luteinizing Hormone Releasing Hormone 52 multipotent 51 RNA antagonists 51 cell nuclei 51 ProMune 51 intestinal epithelium 51 cancer immunotherapies 51 small molecule activator 51 microtubule inhibitor 51 antibody humanization 51 IgG1 monoclonal antibody 51 POTELLIGENT R 51 bipolar wafer 51 FOLOTYN ® 51 JAK1 51 oral Janus kinase 51 candidate deforolimus 51 EHT AGN 51 transmembrane receptor 51 Azacitidine 51 Lpathomab 51 VEGF receptor 51 axonal regeneration 51 inhibits protein synthesis 51 ZBx 51 HSP# inhibitor 51 pancreatic colon 51 AAG geldanamycin analog 51 GPR# agonist 51 ARRY # 51 Liprotamase 51 cell hESC derived 51 progenitor cell 51 Alnylam RNAi 51 gastro intestinal inflammation 51 RainStorm 51 isoform selective 51 Apaziquone 51 regenerative therapeutics 51 Davanat 51 molecularly targeted 51 Sphingomab TM 51 siRNAs targeting 51 siRNA sequences 51 molecular chaperone regulation 51 called thymidine phosphorylase 51 Sertoli cell 51 leukapheresis 51 demethylating agents 51 menadione 51 vascular endothelial cells 51 Annamycin 51 MyVax R 51 #ME# 51 peroxisome 51 histone deacetylase 51 ThermoDox R 51 gefitinib Iressa 51 Virulizin ® 51 ANTISENILIN R 51 Etubics 51 ALN PCS 51 short hairpin RNAs 51 PDL# 51 fibroblast cells 51 tyrosine kinase inhibitor 51 anti CD3 antibody 51 gamma secretase inhibitor 51 Recombinant Human 51 thymosin beta 4 51 Tß4 51 Aganocide TM 51 Inc. OTCBB CYGX 51 proteasome inhibitor 51 Helinx technology 51 ATL# [001] 51 Azedra 51 Vidaza azacitidine 51 IV Busulfex 51 HEK# 51 monocytes macrophages 51 HeLa cell 51 oral JAK1 51 Aganocide ® 51 Dye sensitized solar 51 2 methoxyestradiol 51 Sertoli cells 51 DiLA2 liposomes 51 specific lectin receptors 51 investigational humanized monoclonal antibody 51 Factor VEGF 51 RNAi therapeutic targeting 51 TP Xeloda 51 hES cells 51 anaplastic lymphoma kinase ALK 51 HCV replication 51 Avicena 51 Albugon 51 tkRNAi technology 51 Taligen Therapeutics 51 angiogenesis inhibition 51 AntiCancer 51 Pathway Inhibitor 51 DispersinB ® 51 AtuRNAi 51 AKT inhibitor 51 Leydig cells 51 lysosomal 51 MultiStat 51 Adnectin 51 cyclin dependent kinase inhibitor 51 siRNA constructs 51 Fleximer R 51 aurora kinase 50 PDE# 50 bispecific 50 myeloproliferative disorders 50 hepatocytes liver 50 neural progenitor 50 Pyridorin 50 EBx 50 Cotara ® 50 IL# PE#QQR 50 NF κB 50 custom oligonucleotides 50 ZEVALIN ® 50 ArQule Kinase Inhibitor Platform 50 YONDELIS 50 HepG2 cells 50 Posiphen TM 50 mGluR2 NAM 50 HepDirect R 50 ALK inhibitor 50 MCF7 50 adipose derived 50 ImmunoGen DM1 cancer 50 Lymphocytes 50 Protexia ® 50 transferrin receptors 50 Cyclosporin 50 adipocyte 50 Nanobody 50 VitiGam 50 granulocyte 50 Aplidin R 50 Selective Electrochemical Tumor Ablation 50 Epidermal Growth Factor Receptor 50 Cholestagel 50 patented PICM 50 hypoxic tumor 50 Peptide YY 50 stably transfected 50 Quark Biotech Inc. 50 mononuclear 50 matrix metalloproteinases 50 multipotent stem cells 50 SIRT2 50 immunoregulatory 50 protein synthesis machinery 50 AQUA ® 50 basophils 50 Vegenics 50 Spiegelmer 50 transdifferentiation 50 KRAS mutant 50 cMET 50 HepG2 50 Novavax VLP vaccine 50 Symadex 50 precancerous stem cells 50 mouse neural stem 50 proprietary encapsulation 50 mitotic progression 50 hpSC lines 50 developing Zerenex ferric 50 targeted nucleotide prodrug 50 monocytic 50 Spiegelmers 50 CD# monoclonal antibody 50 somatostatin receptors 50 MAGE A3 ASCI 50 murine monoclonal antibody 50 5 HT4 50 targeted radiotherapeutic 50 Nereus Pharmaceuticals 50 nicotinic alpha 7 50 ON #.Na 50 erythropoiesis 50 Myocet 50 antigenic epitopes 50 HER2 neu 50 co stimulatory molecules 50 malignant ascites 50 AMEX RGN 50 proteinase 50 melanocyte 50 cardiac fibroblasts 50 Vidaza R 50 cinacalcet HCl 50 c MYC 50 investigational oral anticoagulant 50 IAP inhibitor 50 glucagon receptor 50 EGFR HER2 50 receptor molecule 50 CDK inhibitors 50 cells PBMC 50 Adenosine Therapeutics 50 OTCBB PYTO 50 IMiDs R 50 Valortim TM 50 Onco TCS 50 antibody MT# 50 Factor VIIa 50 neural cells 50 mammaglobin 50 human airway epithelial 50 adipose cells 50 selective androgen receptor modulators 50 Presents Preclinical 50 efaproxiral 50 PEG SN# 50 hematopoetic stem cells 50 SERMs 50 Somatuline 50 tubulin inhibitor 50 selective kinase inhibitor 50 Pim kinases 50 resultant PLX PLacental eXpanded 50 alpha#beta# 50 adhesion molecules 50 phosphate S1P 50 flavopiridol 50 cyclophilin inhibitors 50 PSMA antibody 50 cyclin dependent kinases 50 HCV protease inhibitors 50 mesenchymal stem cells MSCs 50 NanoCrystal Technology 50 Novasome 50 TaiGen 50 HuCAL GOLD 49 cell lysis 49 romazarit 49 hESCs 49 ImmuneY2 49 Hypoxia Inducible Factor 49 receptor monoclonal antibody 49 Presents Preclinical Data 49 imatinib Gleevec ® 49 constitutively active 49 β catenin 49 TOCOSOL 49 Initiate Clinical Trial 49 exclusive sublicense 49 nucleotide analog 49 biotherapeutic drugs 49 Lodamin 49 small molecule PEGylation 49 inhibit metastasis 49 Bleomycin 49 CCR1 49 molecular determinants 49 receptor tyrosine kinase 49 glial cell 49 small molecule Hedgehog 49 leukocyte adhesion 49 OHR/AVR# 49 Fibroblast Growth Factor Receptor 49 Memory MRAM 49 LEP ETU 49 Elan NanoCrystal 49 AQ4N 49 GAP #B# 49 protein tyrosine phosphatase 1B 49 zanolimumab 49 retinal pigment epithelium 49 TOCOSOL Camptothecin 49 OTCBB CVBT 49 Biopharma OTCBB VODG 49 signaling cascades 49 epithelial tissues 49 outer membrane proteins 49 CysDisplay 49 synthetic retinoid 49 colony stimulating factors 49 Actimmune ® 49 trans splicing 49 advanced polymer conjugate 49 drug ISA# 49 IGF IR 49 Curaxin 49 cathepsins 49 LentiVector 49 intercellular signaling 49 effector memory 49 Initiates Phase II 49 Neulasta R 49 Zeatin 49 cells overexpressing 49 PKC# 49 cells ESCs 49 Romidepsin 49 JAK inhibitor 49 Epothilones 49 Thymosin beta 4 49 haematologic malignancies 49 breast epithelial cells 49 Antisense Pharma 49 P#X# 49 compound perifosine 49 Odyssey Thera 49 Small Molecule 49 Civacir 49 activin 49 Thrombin topical Recombinant 49 InterfeRx 49 mouse fibroblasts 49 CYT# potent vascular disrupting 49 PARP inhibition 49 polycythemia vera PV 49 CD# antigen 49 OMP #R# 49 Panzem R 49 tkRNAi 49 lymphoid tissue 49 mediated inhibition 49 EGF receptor 49 GRP# 49 QUADRAMET R 49 FUS1 49 prostone 49 EGFR protein 49 autoreactive B 49 undifferentiated stem cells 49 Monoclonal Antibody 49 HQK 49 SR Pharma 49 CTLA4 Ig 49 Src kinase 49 lymphoid organs 49 Cdc7 49 Preclinical Study 49 gastrin 49 GED aPC 49 telomerase inhibitor drug 49 patented Sertolin TM 49 oncoproteins 49 dsRNA 49 lymphoid cells 49 OrthoCyte 49 metastatic colorectal 49 brivanib 49 human mammary epithelial 49 ALN TTR 49 Personalized Immunotherapy 49 Liprostin 49 Tumour Vascular Disrupting Agent 49 Camptothecin 49 hyaluronidase enzyme 49 ZFP technology 49 telomerase inhibitors 49 Cre recombinase 49 pancreatic islet 49 NFκB 49 extracellular matrix proteins 49 EndoTAG TM 49 lymphoblasts 49 Aganocide 49 Mucosal 49 FGFR 49 cyclic AMP cAMP 49 SNS# T 49 Modrenal R 49 hematopoietic progenitors 49 HuLuc# 49 CCR5 mAb 49 ATG Fresenius S 49 endoderm 49 Cathepsin S 49 tiapamil 49 PICM #H 49 samarium Sm 49 EZN 49 Monoclonal antibody 49 cytochrome P 49 glioblastoma cells 49 pRb 49 trastuzumab DM1 T DM1 49 HER2 receptor 49 Therapeutic Competitors companiesandmarkets.com adEgemonye 49 proteosome 49 oral prodrug 49 R roscovitine 49 Galectins 49 PKM2 48 cathepsin B 48 WinRho SDF 48 p# activation 48 ViaCord R 48 DNA hypermethylation 48 podocyte 48 thrombin receptor 48 CCR2 48 nanostructured solar 48 humoral immune response 48 Inc. Nasdaq IMGN 48 stem cell differentiation 48 mTOR mammalian target 48 potent inducer 48 Septin 9 48 radial glia 48 MGd 48 mesenchymal cells 48 HuMax HepC TM 48 T lymphocyte 48 Collaborators Publish 48 Erbitux cetuximab 48 EP #R 48 telomerase gene 48 vacuolar 48 oncoprotein 48 NASDAQ INGN 48 RECALL VAX 48 neuronal nicotinic receptors NNRs 48 pDCs 48 IPSCs 48 aT cell 48 PolyMedix defensin 48 MOG #-# 48 Inc. Nasdaq ALNY 48 NASDAQ ALTH biopharmaceutical 48 FoldRx Pharmaceuticals Inc. 48 SinuNase ™ 48 NeutroPhase TM 48 CCR9 48 Novel Oral 48 hedgehog pathway 48 tranilast 48 Hedgehog pathway inhibitor 48 Cardiomyocytes 48 induced pluripotent 48 embryonic stem ES 48 antiangiogenic 48 Dyax phage display 48 allosteric modulation 48 huC# DM4 48 primordial germ cells 48 PRNewswire FirstCall Neurogen 48 Vidofludimus 48 NV1FGF 48 Aurora Kinase 48 pDC 48 Oncolys 48 hypoxia inducible factor 48 anti secretory 48 immunotherapy treatments 48 Initiates Clinical 48 Chemokine 48 acetonide FA 48 patent EP# 48 cell receptor TCR 48 adult neural stem 48 OvaRex ® MAb 48 EBx ® 48 Romiplostim 48 hepatocytes 48 research anddevelopment 48 Nedd4 48 BioSilicon 48 autophagic 48 Captisol 48 ACAPODENE R 48 candidate epratuzumab 48 transduce 48 Cloretazine 48 selective androgen receptor modulator 48 intestinal epithelial 48 mitogen activated ERK kinase 48 Elafin 48 proximal tubular 48 cell 48 induce apoptosis 48 pro apoptotic proteins 48 TTR gene 48 triphosphate 48 Nanobody ® 48 Cytochrome P# 48 ependymal cells 48 immune modulation 48 bronchial epithelial cells 48 thiazolides 48 sirtuin modulators 48 lysates 48 proliferation apoptosis 48 CD4 + T lymphocytes 48 immunomodulatory effects 48 porphyrins 48 LFRP 48 myeloma cells 48 Exclusive License 48 small molecule defensin 48 Sym# 48 IRX 2 48 Aflibercept 48 SGS# 48 PTP 1B 48 OTCBB CTIX 48 COPREXA ™ 48 Akt activation 48 pro angiogenic 48 cathepsin K inhibitor 48 capillary endothelial cells 48 Kinase Inhibitor 48 acinar 48 Corixa Corporation 48 cells 48 corneal cells 48 CLL cells 48 HDL Selective Delipidation 48 Mersana Therapeutics Inc. 48 compound ISA# 48 novel histone deacetylase 48 Archexin 48 mitogen activated protein kinases 48 tramiprosate 48 phase III isavuconazole 48 Hedgehog antagonist 48 HDAC Inhibitor 48 transcriptional activation 48 hematopoietic cells 48 ISTODAX 48 combinatorial chemistry 48 potent antiproliferative 48 histone deacetylase inhibitors 48 3 kinase PI3K 48 osteoclast 48 Friedreich Ataxia FRDA 48 immune modulator 48 ParAllele 48 Epeius Biotechnologies Corporation 48 Bazedoxifene 48 ubiquitylation 48 nucleolin 48 Enhanze 48 beta globin gene 48 intracellular signaling 48 SMARTICLES 48 Announces Poster Presentations 48 OTCQB CTIX 48 PDX pralatrexate 48 novel orally administered 48 MyVax ® 48 adecatumumab MT# 48 RNAi therapeutic targeting PCSK9 48 proto oncogene 48 pluripotent embryonic 48 NanoCrystal technology 48 PNT# 48 Dynepo TM 48 Isogenica 48 Beta catenin pathway 48 Initiates Enrollment 48 Western blotting 48 enterocytes 47 investigational therapies 47 thymidine 47 cardiomyocytes 47 LiverPool 47 CYCLOSET ® 47 Agios Pharmaceuticals 47 EVIZON TM 47 ARF1 47 IKKß 47 Debio 47 HepaMate 47 selective modulator 47 cellular organelles 47 Busulfex 47 InterfeRx license 47 Mesenchymal 47 cationic lipids 47 HIF 1a 47 non nucleoside inhibitor 47 Angiocept 47 CDDO Im 47 GeoVax AIDS vaccine 47 alefacept 47 R#/MEM 47 non coding RNA 47 lipid membrane 47 PNP inhibitor 47 anticancer agent 47 Fenretinide 47 cells CTCs 47 cell adhesion molecules 47 GPR# [002] 47 Xcytrin R 47 subventricular zone 47 bioactive lipids 47 IMiD 47 TRO# 47 Cintredekin Besudotox 47 Theratope 47 immune modulating 47 Familial Adenomatous Polyposis FAP 47 Microbix Biosystems 47 Rotarix ® 47 B lymphocyte 47 Langerhans cells 47 adipocytes fat 47 Insegia 47 cardiac myocytes 47 microRNA molecule 47 MolecularBreeding ™ 47 Metastatic Melanoma 47 PF # [002] 47 EphB2 47 osteoblast 47 EGFR signaling 47 InNexus Biotechnology 47 lucinactant 47 Darinaparsin 47 lexidronam injection 47 monocrystalline silicon solar 47 placental cells 47 Seikagaku 47 Kahalalide F 47 Zolinza 47 wertheim@wertheim.ca 47 Neuroprotection 47 ligase 47 HUVEC 47 TLK# 47 GW# [003] 47 skin fibroblasts 47 telomerase enzyme 47 tumor infiltrating lymphocytes 47 islet beta 47 Glypromate 47 myofibroblasts 47 DXL# 47 PI3K AKT 47 embryonic germ 47 chemistry immunoassay 47 hyperphosphorylation 47 melanocortin receptor 47 Celator 47 agent bevasiranib 47 Safinamide 47 CBLC# 47 Vion Pharmaceuticals 47 PDE4 inhibitor 47 HCV genotyping 47 ATL# [002] 47 monocyte derived 47 trophoblasts 47 endosomal 47 luciferase reporter 47 hematopoietic blood 47 Velcade bortezomib 47 Neural stem cells 47 MAP kinase 47 unlike tubulin 47 ThermoDox ® clinical 47 Bellicum Pharmaceuticals Inc. 47 nonembryonic 47 rifalazil 47 Allogeneic 47 mediated inflammatory 47 EGF receptors 47 Removab 47 ImmuKnow R 47 aptamer therapeutics 47 Synerx 47 EnVivo 47 embryonic tissue 47 SIRT1 protein 47 dSLIM 47 shRNAs 47 undergo apoptosis 47 PROSTASCINT R 47 Notch pathway 47 motesanib diphosphate 47 MTT assay 47 Vpr 47 microRNA molecules 47 hyperactivated 47 Notch receptors 47 RPE cells 47 APOBEC3G 47 secretory pathway 47 Anti Tumor 47 RKIP 47 histamine dihydrochloride 47 Cloretazine R 47 plasmacytoid dendritic cells 47 preclinically 47 intestinal epithelial cells 47 microglial 47 Sudhir Agrawal D.Phil 47 bevacizumab Avastin ® 47 NaPro 47 Roche Diagnostics GmbH 47 ribonucleic acid RNA 47 receptor PPAR 47 DNA intercalator 47 fluorinated carbohydrate mimics 47 HyACT 47 megakaryocytes 47 intercellular communication 47 nasal calcitonin product 47 EphA2 47 gamma globin gene 47 epithelial 47 PRTX 47 GLP toxicology studies 47 panitumumab Vectibix 47 transgene expression 47 RNA polymerases 47 adhesion proteins 47 membrane lipids 47 secrete proteins 47 NIC5 47 Zenapax 47 chondrocyte 47 Bafetinib 47 cardiomyocyte 47 chromatin structure 47 Pluripotent stem cells 47 Intravenous CP 47 alkylating agent 47 Nexavar sorafenib 47 ERK pathway 47 XNOM 47 C#BL 6 mice 47 Schisandrin B 47 protein tyrosine kinase 47 PRNewswire FirstCall YM BioSciences 47 systemic RNAi therapeutic 47 AMD# [003] 47 RTP# gene 47 Fc receptors 46 Proxinium TM 46 bone marrow stromal cells 46 Inhalation Solution 46 psoriasis rheumatoid arthritis 46 circulating endothelial 46 antifibrotic 46 miRagen 46 leukemic cells 46 Kreutzer Limmer patent 46 Nano Terra 46 Cethrin R 46 vivo validation 46 HeLa cells 46 epigenetic therapies 46 CTCE 46 hES cell 46 phagocytic 46 EnVivo Pharmaceuticals 46 expressing GFP 46 OrbusNeich patented endothelial progenitor 46 oncogenic transformation 46 HOTAIR 46 Inc. NASDAQ ORXE 46 PIP3 46 BioNumerik 46 Ceragenix 46 Helicon Therapeutics 46 glycogen synthase kinase 46 neuroprotective properties 46 Source MDx 46 neurons astrocytes 46 renin inhibitors 46 Saegis Pharmaceuticals 46 SCIB1 46 embryonal carcinoma